November 2009
18 November 2009
SUSTAINED SIX-MONTH IMPORVEMENT IN HEART MUSCLE FUNCTION
BY “OFF-THE-SHELF” ADULT STEM CELLS
SUCCESSFUL BONE MARROW REGENERATION IN CANCER PATIENTS USING CORD BLOOD EXPANDED BY PROPRIETARY STEM CELLS
August 2009
25 August 2009
ANGIOBLAST CLOSES $10M EQUITY-BASED FINANCING
PROPRIETARY TECHNOLOGY IN WORLD-FIRST ALLOGENEIC STEM CELL TRIAL FOR TREATMENT OF END-STAGE HEART FAILURE IN PATIENTS SUPPORTED BY MECHANICAL HEART ASSIST DEVICES
June 2009
24 June 2009
FIRST PATIENTS IN BONE MARROW TRANSPLANT TRIAL SHOW EARLIER ENGRAFTMENT. Potential for accelerated Phase 3 program
November 2008
14 November 2008
FROST & SULLIVAN SELECTS PROPRIETARY TECHNOLOGY
PLATFORM AS U.S. STEM CELL MARKET INNOVATION OF THE YEAR
September 2008
25 September 2008
UBS LIFE SCIENCES INVESTOR CONFERENCE FEATURES ANGIOBLAST
July 2008
10 July 2008
ALLOGENEIC STEM CELLS EFFECTIVELY TREAT EYE DISEASES
June 2008
April 2008
October 2007
30 October 2007
FORMER JOHNSON AND JOHNSON VICE CHAIRMAN JOINS ANGIOBLAST BOARD
September 2007
27 September 2007
ANGIOBLAST FEATURED AT UBS GLOBAL LIFE SCIENCES CONFERENCE IN NEW YORK
August 2007
May 2007
02 May 2007
FDA Clearance Received For Heart Attack Stem Cell Clinical Trial
April 2007
02 April 2007
FDA submission filed for clinical trial of stem cells in heart attack patients
December 2006
01 December 2006
Heart function improves in stem cell trials
March 2006
08 March
Press Release covering Angioblast Human Clinical Trial
February 2006
28 February
Mesoblast announces that Mesoblast and Angioblast well ahead of schedule.
